Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-14250

Single-particle
2.9 Å
EMD-14250 Deposition: 08/02/2022
Map released: 20/04/2022
Last modified: 23/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-14250

Structure of the SARS-CoV-2 spike glycoprotein in complex with the 87G7 antibody Fab fragment

EMD-14250

Single-particle
2.9 Å
EMD-14250 Deposition: 08/02/2022
Map released: 20/04/2022
Last modified: 23/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 spike glycoprotein in complex with the 87G7 antibody Fab fragment
Fitted models: 7r40

Deposition Authors: Hurdiss DL , Drulyte I
An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants of concern.
PUBMED: 35471062
DOI: doi:10.1126/sciimmunol.abp9312
ISSN: 2470-9468